Pharmafile Logo
Pharmafocus logo
Advanced Search

US

Showing 15 posts of 320 posts found.

donald_trump-_image_credit_gage_skidmore

Donald Trump causes confusion as to whether NHS will be ‘on the table’ in trade deal talks

June 6, 2019
Business Services, Medical Communications Donald Trump, NHS, UK, US, healthcare, pharma

President Donald Trump has caused confusion as to whether or not the NHS will ‘be on the table’ in post-Brexit …

News

Healthcare would be ‘on the table’ in post-Brexit trade negotiations with US, Trump’s ambassador says

June 3, 2019
Sales and Marketing J&J, JJ, NHS, UK, US, brexit, healthcare

The American Ambassador to the United Kingdom has said that Britain’s healthcare system would be ‘on the table’ in post-Brexit …

News
gsk_boronia_australia

GSK to reintroduce bonuses for sales reps

May 24, 2019
Medical Communications GSK, US, oncology, pharma, sales, sales reps, scandal

British multinational GlaxoSmithKline said on Thursday that it would reintroduce performance-based bonuses for some sales reps in some countries. The …

News
chinese_flag_beijing_-_img_1104

Chinese pharmaceuticals will not be subject to tariffs, US Trade Representative says

May 14, 2019
Manufacturing and Production China, US, USTR, pharma, tariffs, trade

The Office of the United States Trade Representative (USTR) has said pharmaceuticals will not be subject to potential US tariffs …

News
fda2outsideweb

FDA to end controversial “alternative summary reporting” of medical devices in bid to boost transparency

May 10, 2019
Medical Communications, Research and Development, Sales and Marketing FDA, US, adverse events, medical devices, pharma

The FDA has revealed that it plans to terminate its “alternative summary reporting” programme which has allowed the manufacturers of …

News

US prescription drugs most expensive in world, analysis shows

May 8, 2019
Research and Development Drug pricing, Japan, Ontario, UK, US, prescription drugs

Brand name prescription drugs cost on average 4.3 times more in the United States than in the UK, according to …

News

FDA approves first two drugs for transthyretin amyloid cardiomyopathy

May 7, 2019
Manufacturing and Production, Sales and Marketing FDA, Pfizer, US, Vyndamax, Vyndaqel, pharma

The FDA has approved its first two therapies for the treatment of cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM), …

News
gsk_boronia_australia

GSK’s Benlysta becomes first FDA-approved IV therapy for paediatric lupus

April 30, 2019
Manufacturing and Production, Sales and Marketing Benlysta, FDA, GSK, Lupus, US, pharma

GSK has scored approval in the US with Benlysta (belimumab) for the treatment of systemic lupus erythematosus (SLE) in paediatric …

News
abbvie_0

AbbVie’s Skyrizi snatches up FDA approval in moderate to severe plaque psoriasis

April 24, 2019
Research and Development, Sales and Marketing AbbVie, FDA, Skyrizi, US, pharma, psoriasis

AbbVie has revealed that its interleukin-23 (IL-23) inhibitor Skyrizi (risankizumab-rzaa) has received marketing authorisation in the US from the FDA …

News

Clovis Oncology discontinue phase 2 bladder cancer trial

April 15, 2019
Sales and Marketing Cancer, Clovis Oncology, US, bladder cancer, metastatic bladder cancer

Colorado-based pharma firm Clovis Oncology has said in a filing to the US Securities and Exchange Commission that it is …

News
opioid_pills

Opioid crisis cost US government nearly $38 billion in lost taxes

April 11, 2019
Medical Communications, Research and Development US, government, opioid crisis, opioids, public health, tax revenue

The opioid epidemic may have cost US state and federal governments as much as $37.8 billion in lost tax revenue, …

News
senatefloor

Pharmacy Benefit Manager (PBM) execs testify before US Senate

April 10, 2019
Research and Development PBMs, Rebates, Senate, US, pharma, senator, sfc

Executives representing pharmacy benefit managers (PBMs) appeared before the US Senate Finance Committee on Tuesday as they testified on the …

News

Novartis must face kickback allegations in court

April 2, 2019
Manufacturing and Production Novartis, US, government, kickbacks, prescriptions, whistle blower, whistle-blower

The US government has accused Novartis of paying doctors millions of dollars in kickbacks as part of a “company-wide kickback …

News
vaccination_2

Measles outbreak spurs New York County to ban all unvaccinated children from public spaces

March 27, 2019
Research and Development New York, US, pharma, vaccination, vaccines

Rockland County, New York State, is taking serious measures to combat its biggest measles outbreak in decades, making the decision …

News

FDA advisory panel recommends Sanofi’s dengue vaccine in children, but rejects its use in adults

March 11, 2019
Sales and Marketing FDA, Sanofi, US, Vaccine, dengue, dengvaxia, pharma

Dengvaxia, Sanofi’s vaccine for dengue fever, has been burdened with further negative scrutiny after the FDA’s vaccine advisory panel passed …

News

Latest content

FDA accepts new drug application for Orexo’s opioid overdose medication

November 28, 2023

Arcturus Therapeutics gains FDA ODD for cystic fibrosis treatment

November 28, 2023

Sanofi and Regeneron share results from phase 3 trial for Dupixent as COPD treatment

November 27, 2023

GSK shares results from phase 3 trial for Blenrep as multiple myeloma treatment

November 27, 2023

Alladapt Immunotherapeutics gains FDA Fast Track Designation for ADP101 as food allergy treatment

November 24, 2023